Ca2+-Activated K+ Channel KCa3.1 Regulates Il-10 Expression in Regulatory T Cells at the Recovery Phase of Inflammatory Bowel Disease Model

被引：0
|
作者：
Ohya, Susumu [1 ]
Matsui, Mild [1 ]
Kajikuri, Junko [1 ]
Endo, Kyoko [1 ]
Kito, Hiroaki [1 ]
机构：
[1] Nagoya City Univ, Dept Pharmacol, Sch Med, Nagoya, Aichi, Japan
来源：
BIOPHYSICAL JOURNAL | 2021年 / 120卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
1192-Pos
引用
收藏
页码：246A / 246A
页数：1
相关论文
共 50 条
  • [21] Downregulation of the Ca2+-activated K+ channel KCa3.1 in mouse preosteoblast cells treated with vitamin D receptor agonist
    Kito, Hiroaki
    Morihiro, Haruka
    Sakakibara, Yuka
    Endo, Kyoko
    Kajikuri, Junko
    Suzuki, Takayoshi
    Ohya, Susumu
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2020, 319 (02): : C345 - C358
  • [22] Blunted IgE-mediated activation of mast cells in mice lacking the Ca2+-activated K+ channel KCa3.1
    Shumilina, Ekaterina
    Lam, Rebecca S.
    Woelbing, Florian
    Matzner, Nicole
    Zemtsova, Irina M.
    Sobiesiak, Malgorzata
    Mahmud, Hasan
    Sausbier, Ulrike
    Biedermann, Tilo
    Ruth, Peter
    Sausbier, Matthias
    Lang, Florian
    JOURNAL OF IMMUNOLOGY, 2008, 180 (12): : 8040 - 8047
  • [23] Dominant-Negative, Spliced Variant of the Intermediate-Conductance Ca2+-Activated K+ Channel, KCa3.1 in Lymphoid Cells
    Ohya, Susumu
    Niwa, Satomi
    Yanagi, Ayano
    Fukuyo, Yuka
    Yamamura, Hisao
    Imaizumi, Yuji
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 691A - 692A
  • [24] Realizing its potential -: The intermediate conductance Ca2+-activated K+ channel (KCa3.1) and the regulation of blood pressure
    Fleming, Ingrid
    CIRCULATION RESEARCH, 2006, 99 (05) : 462 - 464
  • [25] Novel Phenolic Inhibitors of Small/IntermediateConductance Ca2+-Activated K+ Channels, KCa3.1 and KCa2.3
    Olivan-Viguera, Aida
    Sofia Valero, Marta
    Divina Murillo, Maria
    Wulff, Heike
    Garcia-Otin, Angel-Luis
    Arbones-Mainar, Jose-Miguel
    Koehler, Ralf
    PLOS ONE, 2013, 8 (03):
  • [26] Ca2+ Activated K+ Channel Kca3.1 as a Determinant of Gastric Acid Secretion
    Rotte, Anand
    Pasham, Venkanna
    Mack, Andreas F.
    Bhandaru, Madhuri
    Qadri, Syed M.
    Eichenmueler, Melanie
    Ruth, Peter
    Lang, Florian
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2011, 27 (05) : 597 - 604
  • [27] KCa3.1 Ca2+-Activated K+ channels regulate human airway smooth muscle proliferation
    Shepherd, Malcolm C.
    Duffy, S. Mark
    Harris, Trudi
    Cruse, Glenn
    Schuliga, Michael
    Brightling, Chris E.
    Neylon, Craig B.
    Bradding, Peter
    Stewart, Alastair G.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2007, 37 (05) : 525 - 531
  • [28] Histidine phosphorylation of the Ca2+-activated K+ channel KCa3.1 by nucleoside diphosphate kinase B (NDPK-B) is required for KCa3.1 channel activation and the reactivation of CD4 T lymphocytes
    Srivastava, Shekhar
    Li, Zhai
    Ko, Kyung
    Choudhury, Papiya
    Albaqumi, Mamdouh
    Johnson, Amanda K.
    Yan, Ying
    Backer, Jonathan
    Unutmaz, Derya
    Coetzee, William A.
    Skolnik, Edward Y.
    BIOPHYSICAL JOURNAL, 2007, : 200A - 200A
  • [29] Intermediate-conductance Ca2+-activated K+ channel, KCa3.1 as a novel therapeutic target for benign prostatic hyperplasia
    Niwa, Satomi
    Ohya, Susumu
    Kojima, Yoshiyuki
    Sasaki, Shoichi
    Sakuragi, Motomu
    Kohri, Kenjiro
    Imaizumi, Yuji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 94P - 94P
  • [30] Intermediate-Conductance Ca2+-Activated K+ Channel, KCa3.1, as a Novel Therapeutic Target for Benign Prostatic Hyperplasia
    Ohya, Susumu
    Niwa, Satomi
    Kojima, Yoshiyuki
    Sasaki, Shoichi
    Sakuragi, Motomu
    Kohri, Kenjiro
    Imaizumi, Yuji
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (02): : 528 - 536
12345